A cross-sectional observational study of the prevalence and characterization of potential QT-prolonging drug‒drug interactions in oncological outpatients
There is a high prevalence of pQT-DDIs in cancer patients. Those receiving multiple anticancer and adjuvant drugs are at higher risk. Routine interaction screening is recommended before chemotherapy.
Authors
- Biswadeep Das (ORCID: https://orcid.org/0000-0002-3222-2527)
- Manjunath Bidarolli (ORCID: https://orcid.org/0000-0001-6686-2154)
- Sachin Manocha (ORCID: https://orcid.org/0000-0001-5216-9244)
- Akash Agnihotri (ORCID: https://orcid.org/0000-0002-3921-0449)
- B. M. Vashisht
Institutions
- Shree Guru Gobind Singh Tricentenary University (IN)
- All India Institute of Medical Sciences Rishikesh (IN)
- Amrita Vishwa Vidyapeetham (IN)
Publication Details
- Journal
- Journal of Basic and Clinical Physiology and Pharmacology
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1515/jbcpp-2024-0104
- Primary Topic
- Cardiac electrophysiology and arrhythmias
- Type
- article
- Field-Weighted Citation Impact
- 0.00